{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:33:36Z","timestamp":1791232416745,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40120-025-00869-w","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T11:39:31Z","timestamp":1764243571000},"page":"257-267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Care Partners\u2019 Perceptions of Amyloid-Targeting Therapy and Treat\u2011to\u2011Clearance for Alzheimer\u2019s Disease in Japan: A Qualitative Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Sadao","family":"Katayama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1967-9829","authenticated-orcid":false,"given":"Kaname","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanako","family":"Shimoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Suo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohisa","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"869_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jalz.2016.07.150","volume":"13","author":"A Wimo","year":"2017","unstructured":"Wimo A, Guerchet M, Ali GC, et al. The worldwide costs of dementia 2015 and comparisons with 2010. Alzheimers Dement. 2017;13:1\u20137.","journal-title":"Alzheimers Dement"},{"key":"869_CR2","unstructured":"Ninomiya T, Ono K, Iga J, Nakajima K, Maeda T, Kokubo Y. Study on the prevalence and future projections of dementia and mild cognitive impairment. Elderly health promotion and wellness initiatives funded by Minister of Health, Labour and Welfare. 2024. https:\/\/www.eph.med.kyushu-u.ac.jp\/jpsc\/uploads\/resmaterials\/0000000111.pdf?1715072186. Accessed 25 Nov 2025."},{"key":"869_CR3","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1017\/S1041610212000841","volume":"24","author":"O Karnieli-Miller","year":"2012","unstructured":"Karnieli-Miller O, Werner P, Aharon-Peretz J, Sinoff G, Eidelman S. Expectations, experiences, and tensions in the memory clinic: the process of diagnosis disclosure of dementia within a triad. Int Psychogeriatr. 2012;24:1756\u201370.","journal-title":"Int Psychogeriatr"},{"key":"869_CR4","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1017\/S1041610216001381","volume":"30","author":"L van de Groen\u2013Ven","year":"2018","unstructured":"van de Groen\u2013Ven L, Smits C, Span M, et al. The challenges of shared decision making in dementia care networks. Int Psychogeriatr. 2018;30:843\u201357.","journal-title":"Int Psychogeriatr"},{"issue":"8","key":"869_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jagp.2013.05.004","volume":"22","author":"H Brodaty","year":"2014","unstructured":"Brodaty H, Woodward M, Boundy K, Ames D, Balshaw R. Prevalence and predictors of burden in caregivers of people with dementia. Am J Geriatr Psychiatry. 2014;22(8):756\u201365. https:\/\/doi.org\/10.1016\/j.jagp.2013.05.004.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"869_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41392-024-01911-3","volume":"9","author":"J Zhang","year":"2024","unstructured":"Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L. Recent advances in Alzheimer\u2019s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduct Target Ther. 2024;9(1):211.","journal-title":"Signal Transduct Target Ther"},{"issue":"45","key":"869_CR7","doi-asserted-by":"publisher","first-page":"37377","DOI":"10.1074\/jbc.M508246200","volume":"280","author":"P Marambaud","year":"2005","unstructured":"Marambaud P, Zhao H, Davies P. Resveratrol promotes clearance of Alzheimer\u2019s disease amyloid-\u03b2 peptides. J Biol Chem. 2005;280(45):37377\u201382. https:\/\/doi.org\/10.1074\/jbc.M508246200.","journal-title":"J Biol Chem"},{"key":"869_CR8","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, et al. Donanemab in early Alzheimer\u2019s disease. N Engl J Med. 2021;384:1691\u2013704.","journal-title":"N Engl J Med"},{"issue":"6","key":"869_CR9","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, et al. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"key":"869_CR10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/gps.4997","volume":"34","author":"B Woods","year":"2019","unstructured":"Woods B, Arosio F, Diaz A, et al. Timely diagnosis of dementia? Family carers\u2019 experiences in 5 European countries. Int J Geriatr Psychiatry. 2019;34:114\u201321.","journal-title":"Int J Geriatr Psychiatry"},{"key":"869_CR11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/13607860410001649653","volume":"8","author":"S Lliffe","year":"2004","unstructured":"Lliffe S, Manthorpe J. Editorial: the hazards of early recognition of dementia: a risk assessment. Aging Ment Health. 2004;8:99\u2013105.","journal-title":"Aging Ment Health"},{"key":"869_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.pneurobio.2013.04.005","volume":"110","author":"ME De Vugt","year":"2013","unstructured":"De Vugt ME, Verhey FRJ. The impact of early dementia diagnosis and intervention on informal caregivers. Prog Neurobiol. 2013;110:54\u201362. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.04.005.","journal-title":"Prog Neurobiol"},{"key":"869_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1609406917733847","volume":"16","author":"LS Nowell","year":"2017","unstructured":"Nowell LS, Norris JM, White DE, Moules NJ. Thematic analysis: striving to meet the trustworthiness criteria. Int J Qual Methods. 2017;16:1\u201313.","journal-title":"Int J Qual Methods"},{"issue":"8","key":"869_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1080\/03007995.2021.1922369","volume":"37","author":"M Nakanishi","year":"2021","unstructured":"Nakanishi M, Igarashi A, Ueda K, Brnabic AJM, Matsumura T, Meguro K, et al. Costs and resource use of community-dwelling patients with Alzheimer\u2019s disease in Japan: 18-month results from the GERAS-J study. Curr Med Res Opin. 2021;37(8):1331\u20139. https:\/\/doi.org\/10.1080\/03007995.2021.1922369.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"869_CR15","first-page":"38","volume":"21","author":"H Watanabe","year":"2015","unstructured":"Watanabe H, Watanabe K. Changes in the feelings and communication of family caregivers during their involvement with elderly individuals with mild dementia. Jpn J Res Fam Nurs. 2015;21(1):38\u201349.","journal-title":"Jpn J Res Fam Nurs"},{"key":"869_CR16","unstructured":"Arai T, Igarashi A, Iwata A, Kasuga K, Niimi Y, Higashi S. Research to examine social issues associated with advances in dementia medical care. General study report 2023. 2023. The Ministry of Health. Labor and Welfare of Japan GRANTS SYSTEM. https:\/\/mhlw-grants.niph.go.jp\/project\/167759. Accessed 25 Nov 2025."},{"issue":"4","key":"869_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/gnaf033","volume":"65","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Sereika S, Seaman J, Pettigrew C, Albert M, Lingler J. Caregivers\u2019 perspectives on discussions of medical treatment preferences for people living with dementia are associated with their dementia health literacy and the caregiving relationship. Gerontologist. 2025;65(4):gnaf033.","journal-title":"Gerontologist"},{"issue":"6","key":"869_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/geront\/20.6.649","volume":"20","author":"SH Zarit","year":"1980","unstructured":"Zarit SH, Reever KE, Bach-Peterson J. Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist. 1980;20(6):649\u201355. https:\/\/doi.org\/10.1093\/geront\/20.6.649.","journal-title":"Gerontologist"},{"key":"869_CR19","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1007\/s11136-015-1011-x","volume":"24","author":"SE Rand","year":"2015","unstructured":"Rand SE, Malley JN, Netten AP, Forder JE. Factor structure and construct validity of the Adult Social Care Outcomes Toolkit for Carers (ASCOT-Carer). Qual Life Res. 2015;24:2601\u201314.","journal-title":"Qual Life Res"},{"issue":"2","key":"869_CR20","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200127","volume":"13","author":"AM Wessels","year":"2023","unstructured":"Wessels AM, Dennehy EB, Dowsett SA, Dickson SP, Hendrix SB. Meaningful clinical changes in Alzheimer disease measured with the iADRS and illustrated using the Donanemab TRAILBLAZER-ALZ study findings. Neurol Clin Pract. 2023;13(2):e200127. https:\/\/doi.org\/10.1212\/CPJ.0000000000200127.","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"869_CR21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.trci.2017.04.002","volume":"3","author":"M Kunneman","year":"2017","unstructured":"Kunneman M, Pel\u2010Littel R, Bouwman FH, Gillissen F, Schoonenboom NSM, Claus JJ, et al. Patients\u2019 and caregivers\u2019 views on conversations and shared decision making in diagnostic testing for Alzheimer\u2019s disease: the ABIDE project. Alzheimer\u2019s Dement Transl Res Clin Interv. 2017;3(3):314\u201322. https:\/\/doi.org\/10.1016\/j.trci.2017.04.002.","journal-title":"Alzheimer's Dement Transl Res Clin Interv"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-025-00869-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-025-00869-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T13:51:43Z","timestamp":1768398703000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-025-00869-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["869"],"URL":"https:\/\/doi.org\/10.1007\/s40120-025-00869-w","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sadao Katayama received consultancy fees from Eisai Co. Ltd. Kanako Shimoura and Shintaro Suo are employees of Mebix, Inc, which was outsourced by Eli Lilly and Company to perform this study. Kaname Ueda and Naohisa Hatakeyama are employees of Eli Lilly Japan K.K. and hold shares in Eli Lilly and Company. Masashi Tsujimoto and Keisuke Suzuki have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki, Ethical Guidelines for Medical and Biological Research involving Human Subjects, and Japanese laws and regulations, and was approved by the Takahashi Clinic Ethics Committee (LNW00216). To enroll in this study, all participants were asked for and provided written informed consent. All of the data collected were processed and stored in accordance with the law on the protection of personal information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}